phase II
enrolling now

The Type 2 Diabetes & Kidney Health Trial

For adults aged 18-75 with type 2 diabetes, come in for a kidney health check. Conducted at our Brisbane and Morayfield clinics.
Age 18 - 75
day visits
Up to $1400
About this trial

A potential new treatment to improve kidney function in those with type 2 diabetes

Type 2 diabetes (T2D) occurs when the body can't use insulin, the hormone that moves sugar from the bloodstream into the body's cells for energy. As blood sugar levels remain high over time, they can damage the small blood vessels throughout the body, including those in the kidneys. When the kidneys become damaged, they can no longer filter waste and excess fluid as effectively as they should. This condition, known as diabetic kidney disease, affects half of all people living with diabetes.

One of the challenges of diabetic kidney disease is that it often develops silently. Many people experience no symptoms in the early stages, allowing kidney damage to progress unnoticed. While there is currently no cure, early detection can make a significant difference. 

Identifying kidney disease sooner may help slow its progression, preserve kidney function, and improve long-term health outcomes. This is why regular kidney health checks, along with continued research into new treatment options, are so important. 

This clinical trial is investigating a potential new treatment for kidney disease caused by Type 2 diabetes. Researchers are assessing the treatment's safety and tolerability, and whether it may help support kidney health. We are offering a free kidney health check for people diagnosed with T2D. The screening may provide valuable insights into your kidney health and could determine whether you are eligible to participate in this important research.
The investigational treatment is given as an injection under the skin of the upper arm, abdomen or thigh. The treatment is being compared to a placebo, and participants have a 3 in 4 chance (75%) of receiving the investigational product rather than the placebo.
Eligibility

Do you qualify?

Aged 18–75
Have a diagnosis of Type 2 diabetes
BMI between 18.5 and 40 (not sure of your BMI? Check here)
Are not currently taking any injectable GLP-1 medications
If taking blood pressure or diabetes medications (Antihypertensive and/or antidiabetic medications), stable dose for at least 3 months
What's involved

Commitment and procedures

Visit type
day visits
total visits
9-14
duration
30 weeks
treatment
Injection

procedures

Physical examination
Vital signs monitoring
ECG (electrocardiogram)
Blood and urine sample collection
Monitoring of protein levels in urine
Monitoring of kidney function
Questionnaires
Study drug injection

treatment design

Participants will attend 9-14 visits for approximately 7 months at our Brisbane or Morayfield clinics. The investigational treatment is given as an injection under the skin. 

The treatment is being compared to a placebo, and participants have a 3 in 4 chance (75%) of receiving the investigational product rather than the placebo.

Participants will keep their usual cholesterol-lowering medication unless changes are medically necessary.
More information

Have questions? We're here to help.

Contact our recruitment team directly, they're happy to answer any questions before you apply. Please do not send personal medical information by email.
Phone
+07 5409 8640
Hours
Mon–Fri, 8am–5pm
Trial at a glance
Status
enrolling
Phase
phase II
Therapeutic Area
Ages
18 - 75
Duration
30 weeks
Visits
9-14 visits
Location
Brisbane and Morayfield clinics
PROTOCOL
IGT-303-CKD01
Reimbursement
Up to $1400

Ready to check your eligibility?

It takes less than 2 minutes to fill out our chronic kidney disease trial form.
Apply for this trial →
We won't share your details with third parties.
This trial has been reviewed by an independent human research ethics committee.

Not the right trial?

Browse all trials
UniSC Clinical Trials South East Queensland
South East Queensland's most active clinical research network, connecting communities, clinicians and global sponsors since 2015.
Copywriting © 2026 UniSC Clinical Trials
envelopephone-handsetmap-marker
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram